Dishman Carbogen Amcis Ltd
NSE:DCAL

Watchlist Manager
Dishman Carbogen Amcis Ltd Logo
Dishman Carbogen Amcis Ltd
NSE:DCAL
Watchlist
Price: 230.01 INR -3.35% Market Closed
Market Cap: 36.1B INR
Have any thoughts about
Dishman Carbogen Amcis Ltd?
Write Note

Dishman Carbogen Amcis Ltd
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dishman Carbogen Amcis Ltd
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Dishman Carbogen Amcis Ltd
NSE:DCAL
Depreciation & Amortization
â‚ą3.1B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Depreciation & Amortization
â‚ą3.8B
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Suven Life Sciences Ltd
NSE:SUVEN
Depreciation & Amortization
â‚ą53.8m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Depreciation & Amortization
â‚ą4.4B
CAGR 3-Years
15%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Tarsons Products Ltd
NSE:TARSONS
Depreciation & Amortization
â‚ą404m
CAGR 3-Years
44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
Innova Captab Ltd
NSE:INNOVACAP
Depreciation & Amortization
â‚ą159.6m
CAGR 3-Years
42%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dishman Carbogen Amcis Ltd
Glance View

Market Cap
36.1B INR
Industry
Life Sciences Tools & Services

Dishman Carbogen Amcis Ltd. is a manufacturing company, which engages in the provision of outsourcing services for the pharmaceutical industry. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-09-21. The firm's segments include CRAMS and Vitamin - D, Bulk Drugs, Quats, Specialty Chemicals and traded goods. The firm assists pharma companies through various stages of drug development from process research and development to late-stage clinical and commercial manufacturing facilities, along with the supply of active pharmaceutical ingredients (APIs) and intermediates. The firm has manufacturing and research facilities in India, Switzerland, France, Netherlands, United Kingdom and China. The firm's subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., Dishman Carbogen Amcis (Singapore) Pte. Ltd., CARBOGEN AMCIS Holding AG and Dishman Biotech Ltd.

DCAL Intrinsic Value
253.24 INR
Undervaluation 9%
Intrinsic Value
Price

See Also

What is Dishman Carbogen Amcis Ltd's Depreciation & Amortization?
Depreciation & Amortization
3.1B INR

Based on the financial report for Sep 30, 2024, Dishman Carbogen Amcis Ltd's Depreciation & Amortization amounts to 3.1B INR.

What is Dishman Carbogen Amcis Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
0%

Over the last year, the Depreciation & Amortization growth was 11%.

Back to Top